Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Vicky Makker"'
Autor:
Nicoletta Colombo, Domenica Lorusso, Bradley J. Monk, Brian Slomovitz, Kosei Hasegawa, Angélica Nogueira-Rodrigues, Melissa Zale, Chinyere E. Okpara, Gianmaria Barresi, Jodi McKenzie, Vicky Makker
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 12, Pp 62-75 (2023)
Background. Lenvatinib plus pembrolizumab significantly improved efficacy compared with chemotherapy in patients with advanced endometrial cancer (aEC) regardless of microsatellite instability status or histologic subtype, who had disease progression
Externí odkaz:
https://doaj.org/article/710c4a0b98014278bf805931cfc7c196
Autor:
Razvan Cristescu, Andrey Loboda, Robert Orlowski, Vicky Makker, Matthew H Taylor, Carol Aghajanian, Petar Jelinic, Lea Dutta, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Lenvatinib plus pembrolizumab demonstrated clinically meaningful benefit in patients with previously treated advanced endometrial carcinoma in Study 111/KEYNOTE-146 (NCT02501096). In these exploratory analyses from this study, we evaluated
Externí odkaz:
https://doaj.org/article/1aba98f370d441fabd9fdd926cef1538
Autor:
William Foulsham, Benjeil Z. Edghill, O.D. Julia Canestraro, Vicky Makker, Jason Konner, David H. Abramson, Jasmine H. Francis
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 27, Iss , Pp 101657- (2022)
Purpose: To report a case of central retinal vein occlusion (CRVO) in a patient being treated with a fibroblast growth factor receptor (FGFR) inhibitor. Observations: A 54-year-old female patient with endometrial cancer presented with CRVO and cystoi
Externí odkaz:
https://doaj.org/article/6e3d4e9fcb8e4730aad4c520ad3dc8fe
Autor:
Elizabeth H. Stover, Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak, Russell R. Broaddus, Vicky Makker, Ronny Drapkin, Joyce F. Liu, Neil S. Horowitz, Funda Meric-Bernstam, Carol Aghajanian, Robert L. Coleman, Gordon B. Mills, Lewis C. Cantley, Ursula A. Matulonis, Shannon N. Westin, Panagiotis A. Konstantinopoulos
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100974- (2022)
Uterine serous carcinoma (USC) is an uncommon subtype of endometrial cancer with a poor prognosis. USCs have genomic alterations in the PI3K pathway. A prior phase II study of AKT inhibitor MK-2206 (an allosteric AKT inhibitor, primarily affecting AK
Externí odkaz:
https://doaj.org/article/9a6dad8bf1b54f1fada0cfe8b5c09232
Autor:
Harini Veeraraghavan, Claire F. Friedman, Deborah F. DeLair, Josip Ninčević, Yuki Himoto, Silvio G. Bruni, Giovanni Cappello, Iva Petkovska, Stephanie Nougaret, Ines Nikolovski, Ahmet Zehir, Nadeem R. Abu-Rustum, Carol Aghajanian, Dmitriy Zamarin, Karen A. Cadoo, Luis A. Diaz, Mario M. Leitao, Vicky Makker, Robert A. Soslow, Jennifer J. Mueller, Britta Weigelt, Yulia Lakhman
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract To evaluate whether radiomic features from contrast-enhanced computed tomography (CE-CT) can identify DNA mismatch repair deficient (MMR-D) and/or tumor mutational burden-high (TMB-H) endometrial cancers (ECs). Patients who underwent targete
Externí odkaz:
https://doaj.org/article/039f6ea3eee241349cd91ff919a41db5
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss , Pp 100844- (2021)
Externí odkaz:
https://doaj.org/article/f77b6caec2c9418da553015b4fc61471
Autor:
Maria Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N. Grisham, Carol Aghajanian, Karen Cadoo
Publikováno v:
Gynecologic Oncology Reports, Vol 28, Iss , Pp 120-123 (2019)
Women with endometrial cancer (EC) frequently receive adjuvant paclitaxel and carboplatin (PC) chemotherapy. There is no standard first line chemotherapy at disease recurrence. Data extrapolated from ovarian cancer has suggested that patients with re
Externí odkaz:
https://doaj.org/article/86f7c2de217047ad921af68134b4efbd
Autor:
Paulina Cybulska, Marina Stasenko, Raanan Alter, Vicky Makker, Karen A. Cadoo, Yukio Sonoda, Nadeem R. Abu-Rustum, Jennifer J. Mueller, Mario M. Leitao, Jr.
Publikováno v:
Gynecologic Oncology Reports, Vol 26, Iss , Pp 87-90 (2018)
Objective: To report characteristics of patients with low-grade endometrioid endometrial carcinoma (EC) who develop brain metastases. Methods: We retrospectively identified all patients treated at our institution for FIGO grades 1/2 EC from 1/2000–
Externí odkaz:
https://doaj.org/article/e9a0fe5b72dd4783a0910a5ba87e6b45
Autor:
Syed S. Mahmood, Carol L. Chen, Natalie Shapnik, Udhay Krishnan, Harsimran S. Singh, Vicky Makker
Publikováno v:
Gynecologic Oncology Reports, Vol 25, Iss , Pp 74-77 (2018)
Background: Fulminant myocarditis has been reported in patients treated with immune checkpoint inhibitors. We present the first described case of acute immune-mediated myocarditis and myositis associated with durvalumab plus tremelimumab combination
Externí odkaz:
https://doaj.org/article/8f77b67a0be24fe9be462f7fa7e34faa
Autor:
Madhuri Martin, Joshua K. Sabari, Gulisa Turashvili, Darragh F. Halpenny, Hira Rizvi, Natalie Shapnik, Vicky Makker
Publikováno v:
Gynecologic Oncology Reports, Vol 24, Iss , Pp 94-98 (2018)
Introduction: Multiple primary tumors (MPTs) are defined as two or more separate synchronous or metachronous neoplasms occurring in different sites in the same individual. These tumors differ in histology, as well as primary sites from which they ari
Externí odkaz:
https://doaj.org/article/6e70fb5073294f24a54a2fa8f20d3a78